News & Insights

Patenting psychedelic medicines

Patenting psychedelic medicines, delivery technologies and treatment paradigms provides manufacturers with a period of market exclusivity, incentivising innovation by enabling

Read More

Psychedelic profiles: LSD

Psychedelic profiles LSD Lysergic acid diethylamide is a synthetic serotonergic psychedelic. It binds to both serotonin and dopamine receptors, in

Read More

Psychedelic profiles: ketamine

Psychedelic profiles Ketamine In 2021 the psychedelic healthcare market was worth US$190 million, dominated by ketamine-assisted therapy. Distinct from other

Read More
1 2 3 4 5 6 9